3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2/3
1
Phase 1/2
1
Status
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Pancreatic Neoplasms
4
Colorectal Neoplasms
2
Resectable Pancreatic Cancer
1
Rectal Neoplasms
1
Pancreatic Cancer Non-resectable
1
Pancreatic Cancer Metastatic
1
Interventions
Fluorouracil
131
Leucovorin
127
Oxaliplatin
93
Bevacizumab
86
Irinotecan
74
Capecitabine
63
Cetuximab
47
Folfox protocol
32
Panitumumab
18
regorafenib
16
trifluridine tipiracil drug combination
15
Drug Therapy
14
Chemotherapy, Adjuvant
13
IFL protocol
10
Floxuridine
10
Radiotherapy
9
Tegafur
7
Neoadjuvant Therapy
7
Levoleucovorin
7
Laparoscopy
7
Aspirin
7
pembrolizumab
6
Trifluridine
6
Celecoxib
6
atezolizumab
5
XELOX
5
Mitomycin
5
Colonoscopy
5
tipiracil
4
sintilimab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Colorectal Neoplasms
×
folfirinox
×
Clear all
NCT07340567
2026-01-14
CIRCULATEIII
UNICANCER
Phase 3
Not yet recruiting
2,450 enrolled
NCT05081687
2023-10-11
BRAZIL-TNT
Hospital Israelita Albert Einstein
Phase 3
Unknown
150 enrolled